Related posts
BoC cuts again, but markets flatStocks slide on hawkish Fed commentsMarkets pause, awaiting earningsThis summary was created by AI, based on 12 opinions in the last 12 months.
Mondelez International Inc. (MDLZ) has received mixed reviews from experts, highlighting its solid brand portfolio and market position as well as its challenges in growth and valuation. While the company is praised for its ability to manage cost increases and maintain strong consumer demand during the pandemic, there are concerns about its growth potential, particularly with increasing economic pressures on discretionary spending and the impact of weight-loss drugs. With a significant portion of revenue coming from international markets, the strong U.S. dollar poses additional challenges. Experts note that MDLZ trades at an 18-20x earnings multiple, which may not reflect robust growth, leading to concerns over its current valuation in a competitive landscape. Overall, while the stock shows potential for stable income due to its dividend, long-term growth prospects may hinder its appeal to investors looking for higher returns.
International snack giant. 200-day MA is sideways to slightly negative, stock price is now below it. Fundamentals show only mid-single-digit earnings growth, paying 20x for it. Cost pressures, margin compression. Intense competition. Foreign currency has not helped.
For a consumer staples name, look at Loblaw or COST.
Still likes it. Concern now is that with higher interest rates and rising unemployment, consumers are being more price-conscious. Company has acknowledged this in its biscuit category.
Reassessing pricing and packaging. EMs are about 40% of sales, she sees higher growth there. Selling assets, redeploying proceeds in higher-growth adjacent categories.
Nothing much has changed in MDLZ’s fundamentals over the years, except the valuation has gone down and it is now trading at 18.8x times' Forward P/E ( a fair valuation given MDLZ consistently has traded above 20x). The leverage level has gone down meaningfully in recent years, and the net debt/EBITDA level is now at 1.9x, the lowest in years, indicating a capacity for raising dividends or buying back shares. The company has been a predictable grower, and we think MDLZ would be comfortable to grow 3%-5% for a very long time, it is an attractive dividend grower over time, but the business is mature and fairly low growth overall. We would be OK owning it for income but otherwise do not see it as overly interesting.
Unlock Premium - Try 5i Free
At the time of this pick, GLP weight-loss drugs were creating overhang on the stock. Very well run. Great presence internationally. Recent quarter underwhelming, lower-income US consumer starting to get pressured. Happy to hold due to market dominance and attractive valuation.
MONDELEZ INTERNATIONAL INC Common Stock is a American stock, trading under the symbol MDLZ-Q on the NASDAQ (MDLZ). It is usually referred to as NASDAQ:MDLZ or MDLZ-Q
In the last year, 11 stock analysts published opinions about MDLZ-Q. 4 analysts recommended to BUY the stock. 6 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for MONDELEZ INTERNATIONAL INC Common Stock.
MONDELEZ INTERNATIONAL INC Common Stock was recommended as a Top Pick by on . Read the latest stock experts ratings for MONDELEZ INTERNATIONAL INC Common Stock.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
11 stock analysts on Stockchase covered MONDELEZ INTERNATIONAL INC Common Stock In the last year. It is a trending stock that is worth watching.
On 2025-04-15, MONDELEZ INTERNATIONAL INC Common Stock (MDLZ-Q) stock closed at a price of $67.03.
Buying Hershey's will be a large purchase for them. MDLZ is attractively priced, but he wouldn't buy. He prefers Lindt, which has outperformed. But he likes staples at this part of the cycle.